Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8458)
All Articles published online
|
Feb 28, 2012 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi M, Yu DH, Chen Y, Zhao CY, Zhang J, Liu QH, Ni CR, Zhu MH. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J Gastroenterol 2012; 18(8): 840-846 [PMID: 22371645 DOI: 10.3748/wjg.v18.i8.840] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i8/840.htm |
| Number | Citing Articles |
| 1 |
Elizabeth K. Duperret, Aspen Trautz, Dylan Ammons, Alfredo Perales-Puchalt, Megan C. Wise, Jian Yan, Charles Reed, David B. Weiner. Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice. Clinical Cancer Research 2018; 24(5): 1190 doi: 10.1158/1078-0432.CCR-17-2033
|
| 2 |
Peng Ruan, Zezhang Tao, Aili Tan. Low expression of miR-30a-5p induced the proliferation and invasion of oral cancer via promoting the expression of FAP. Bioscience Reports 2018; 38(1) doi: 10.1042/BSR20171027
|
| 3 |
Rita Saúde-Conde, Ayça Arçay Öztürk, Kosta Stosic, Oier Azurmendi Senar, Julie Navez, Christelle Bouchart, Tatjana Arsenijevic, Patrick Flamen, Jean-Luc Van Laethem. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging. Biomedicines 2024; 12(3): 591 doi: 10.3390/biomedicines12030591
|
| 4 |
Dongtang Yuan, Beibei Liu, Kaixiang Liu, Guotai Zhu, Zhitang Dai, Yue Xie. Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma. Journal of Surgical Oncology 2013; 108(3): 157 doi: 10.1002/jso.23368
|
| 5 |
H Wang, Q Wu, Z Liu, X Luo, Y Fan, Y Liu, Y Zhang, S Hua, Q Fu, M Zhao, Y Chen, W Fang, X Lv. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death & Disease 2014; 5(4): e1155 doi: 10.1038/cddis.2014.122
|
| 6 |
David Vetvicka, Ladislav Sivak, Chinmay M. Jogdeo, Raj Kumar, Rubayat Khan, Yu Hang, David Oupický. Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?. Journal of Controlled Release 2021; 331: 246 doi: 10.1016/j.jconrel.2021.01.020
|
| 7 |
Ryoichi Katsube, Kazuhiro Noma, Toshiaki Ohara, Noriyuki Nishiwaki, Teruki Kobayashi, Satoshi Komoto, Hiroaki Sato, Hajime Kashima, Takuya Kato, Satoru Kikuchi, Hiroshi Tazawa, Shunsuke Kagawa, Yasuhiro Shirakawa, Hisataka Kobayashi, Toshiyoshi Fujiwara. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81465-4
|
| 8 |
Martin Nurmik, Pit Ullmann, Fabien Rodriguez, Serge Haan, Elisabeth Letellier. In search of definitions: Cancer‐associated fibroblasts and their markers. International Journal of Cancer 2020; 146(4): 895 doi: 10.1002/ijc.32193
|
| 9 |
Eliane Cortez, Pernilla Roswall, Kristian Pietras. Functional subsets of mesenchymal cell types in the tumor microenvironment. Seminars in Cancer Biology 2014; 25: 3 doi: 10.1016/j.semcancer.2013.12.010
|
| 10 |
Katharina Dendl, Stefan A. Koerber, Clemens Kratochwil, Jens Cardinale, Rebecca Finck, Mardjan Dabir, Emil Novruzov, Tadashi Watabe, Vasko Kramer, Peter L. Choyke, Uwe Haberkorn, Frederik L. Giesel. FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?. Cancers 2021; 13(19): 4946 doi: 10.3390/cancers13194946
|
| 11 |
Martijn A. van Dam, Floris A. Vuijk, Judith A. Stibbe, Ruben D. Houvast, Saskia A. C. Luelmo, Stijn Crobach, Shirin Shahbazi Feshtali, Lioe-Fee de Geus-Oei, Bert A. Bonsing, Cornelis F. M. Sier, Peter J. K. Kuppen, Rutger-Jan Swijnenburg, Albert D. Windhorst, Jacobus Burggraaf, Alexander L. Vahrmeijer, J. Sven D. Mieog. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy. Cancers 2021; 13(23): 6088 doi: 10.3390/cancers13236088
|
| 12 |
Hiromitsu Maehira, Toru Miyake, Hiroya Iida, Aya Tokuda, Haruki Mori, Daiki Yasukawa, Ken-ichi Mukaisho, Tomoharu Shimizu, Masaji Tani. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population. Annals of Surgical Oncology 2019; 26(13): 4791 doi: 10.1245/s10434-019-07891-x
|
| 13 |
Yuriko Mori, Katharina Dendl, Emil Novruzov, Stefan Körber, Frederik L. Giesel. PET/CT-Atlas. 2024; : 725 doi: 10.1007/978-3-662-67192-4_31
|
| 14 |
Yanghongyan Jiang, Yaxin Tian, Bei Feng, Tingting Zhao, Liang Du, Xiaodong Yu, Qian Zhao. A novel molecular imaging probe [99mTc]Tc-HYNIC-FAPI targeting cancer-associated fibroblasts. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30806-6
|
| 15 |
Paula E. Borgonje, Louise M. Andrews, Gerarda J. M. Herder, John M. H. de Klerk. Performance and Prospects of [68Ga]Ga-FAPI PET/CT Scans in Lung Cancer. Cancers 2022; 14(22): 5566 doi: 10.3390/cancers14225566
|
| 16 |
Martin C. Whittle, Sunil R. Hingorani. Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets. Gastroenterology 2019; 156(7): 2085 doi: 10.1053/j.gastro.2018.12.044
|
| 17 |
Stephanie L. Slania, Deepankar Das, Ala Lisok, Yong Du, Zirui Jiang, Ronnie C. Mease, Steven P. Rowe, Sridhar Nimmagadda, Xing Yang, Martin G. Pomper. Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules. Journal of Medicinal Chemistry 2021; 64(7): 4059 doi: 10.1021/acs.jmedchem.0c02171
|
| 18 |
Adéla Šimková, Petr Bušek, Aleksi Šedo, Jan Konvalinka. Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2020; 1868(7): 140409 doi: 10.1016/j.bbapap.2020.140409
|
| 19 |
Jean Albrengues, Isabelle Bourget, Catherine Pons, Vincent Butet, Paul Hofman, Sophie Tartare-Deckert, Chloe C. Feral, Guerrino Meneguzzi, Cedric Gaggioli. LIF Mediates Proinvasive Activation of Stromal Fibroblasts in Cancer. Cell Reports 2014; 7(5): 1664 doi: 10.1016/j.celrep.2014.04.036
|
| 20 |
Amir Savardashtaki, Zahra Shabaninejad, Ahmad Movahedpour, Roxana Sahebnasagh, Hamed Mirzaei, Michael R Hamblin. miRNAs derived from cancer-associated fibroblasts in colorectal cancer. Epigenomics 2019; 11(14): 1627 doi: 10.2217/epi-2019-0110
|
| 21 |
Jiefu Jin, James D. Barnett, Balaji Krishnamachary, Yelena Mironchik, Catherine K. Luo, Hisataka Kobayashi, Zaver M. Bhujwalla. Evaluating near‐infrared photoimmunotherapy for targeting fibroblast activation protein‐α expressing cells in vitro and in vivo. Cancer Science 2023; 114(1): 236 doi: 10.1111/cas.15601
|
| 22 |
Xinying Hu, Tao Zhou, Jiazhong Ren, Jinghao Duan, Hongbo Wu, Xiaoli Liu, Zhengshuai Mu, Ning Liu, Yuchun Wei, Shuanghu Yuan. Response Prediction Using18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy. Journal of Nuclear Medicine 2023; 64(4): 625 doi: 10.2967/jnumed.122.264638
|
| 23 |
Cole R. Drifka, Agnes G. Loeffler, Kara Mathewson, Adib Keikhosravi, Jens C. Eickhoff, Yuming Liu, Sharon M. Weber, W. John Kao, Kevin W. Eliceiri. Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection. Oncotarget 2016; 7(46): 76197 doi: 10.18632/oncotarget.12772
|
| 24 |
Yongchen Ma, Jing Zhu, Shanwen Chen, Tengyu Li, Ju Ma, Shihao Guo, Jianwen Hu, Taohua Yue, Junling Zhang, Pengyuan Wang, Xin Wang, Guowei Chen, Yucun Liu. Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0599-7
|
| 25 |
Jie Ding, Jiangdong Qiu, Zhixin Hao, Hua Huang, Qiaofei Liu, Wenjing Liu, Chao Ren, Marcus Hacker, Taiping Zhang, Wenming Wu, Li Huo, Xiang Li. Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics. European Journal of Nuclear Medicine and Molecular Imaging 2023; 50(6): 1780 doi: 10.1007/s00259-022-06100-4
|
| 26 |
CUIXIA CAI, RONG SHI, YUAN GAO, JUN ZENG, MIN WEI, HANDUO WANG, WENLING ZHENG, WENLI MA. Reduced expression of sushi domain containing 2 is associated with progression of non-small cell lung cancer. Oncology Letters 2015; 10(6): 3619 doi: 10.3892/ol.2015.3737
|
| 27 |
Chao Zeng, Ming Wen, Xiaomei Liu. Fibroblast activation protein in osteosarcoma cells promotes angiogenesis via AKT and ERK signaling pathways. Oncology Letters 2018; doi: 10.3892/ol.2018.8027
|
| 28 |
Boju Pan, Quan Liao, Zheyu Niu, Li Zhou, Yupei Zhao. Cancer-associated fibroblasts in pancreatic adenocarcinoma. Future Oncology 2015; 11(18): 2603 doi: 10.2217/fon.15.176
|
| 29 |
Hyunjin Park, Yangkyu Lee, Hyejung Lee, Jin-Won Kim, Jin-Hyeok Hwang, Jaihwan Kim, Yoo-Seok Yoon, Ho-Seong Han, Haeryoung Kim. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Tumor Biology 2017; 39(10): 101042831771840 doi: 10.1177/1010428317718403
|
| 30 |
Daphne N. Dorst, Esther M. M. Smeets, Christian Klein, Cathelijne Frielink, Daan Geijs, Marija Trajkovic-Arsic, Phyllis F. Y. Cheung, Martijn W. J. Stommel, Martin Gotthardt, Jens T. Siveke, Erik H. J. G. Aarntzen, Sanne A. M. van Lith. Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma. Molecular Pharmaceutics 2023; 20(8): 4319 doi: 10.1021/acs.molpharmaceut.3c00453
|
| 31 |
Bailee H. Sliker, Paul M. Campbell. Fibroblasts Influence the Efficacy, Resistance, and Future Use of Vaccines and Immunotherapy in Cancer Treatment. Vaccines 2021; 9(6): 634 doi: 10.3390/vaccines9060634
|
| 32 |
Mohammad Javad Mousavi, Jafar Karami, Masoumeh Alimohammadi, Farid Solaymani-Mohammadi, Nima Rezaei. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_357-1
|
| 33 |
D. V. Tyulkina, V. V. Pleshkan, I. V. Alekseenko, M. R. Kopantseva, E. D. Sverdlov. Expression of the FAP gene in non-fibroblast human cell lines. Development of cancer-associated fibroblast models. Doklady Biochemistry and Biophysics 2016; 470(1): 319 doi: 10.1134/S1607672916050033
|
| 34 |
Han Ren, Xiang-Zhong Zeng, Xiao-Xiao Zhao, Da-yong Hou, Haodong Yao, Muhammad Yaseen, Lina Zhao, Wan-hai Xu, Hao Wang, Li-Li Li. A bioactivated in vivo assembly nanotechnology fabricated NIR probe for small pancreatic tumor intraoperative imaging. Nature Communications 2022; 13(1) doi: 10.1038/s41467-021-27932-y
|
| 35 |
Dengsai Peng, Jing He, Hanxiang Liu, Jianpeng Cao, Yingwei Wang, Yue Chen. FAPI PET/CT research progress in digestive system tumours. Digestive and Liver Disease 2022; 54(2): 164 doi: 10.1016/j.dld.2021.07.011
|
| 36 |
Jo Kurosawa, Katsunobu Tawada, Rintaro Mikata, Takeshi Ishihara, Toshio Tsuyuguchi, Masayoshi Saito, Ryota Shimofusa, Hideyuki Yoshitomi, Masayuki Ohtsuka, Masaru Miyazaki, Osamu Yokosuka. Prognostic relevance of apparent diffusion coefficient obtained by diffusion‐weighted MRI in pancreatic cancer. Journal of Magnetic Resonance Imaging 2015; 42(6): 1532 doi: 10.1002/jmri.24939
|
| 37 |
Emil Novruzov, Frederik L. Giesel, Yuriko Mori, Peter L. Choyke, Mardjan Dabir, Eduards Mamlins, Dominik Schmitt, Christina Antke, Claudio Pinto, Cristian Soza-Ried, Rene Fernandez, Horacio Amaral, Vasko Kramer, Leonardo Badinez. Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [18F]FAPI-74 with [18F]FDG in Patients with PDAC: A Prospective Exploratory Study. Cancers 2023; 15(10): 2798 doi: 10.3390/cancers15102798
|
| 38 |
Chien-shan Cheng, Pei-wen Yang, Yun Sun, Shao-li Song, Zhen Chen. Fibroblast activation protein-based theranostics in pancreatic cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.969731
|
| 39 |
Yaqing Zhao, Jiazhong Ren. 18F-FAPI-04 PET/CT parameters predict PD-L1 expression in esophageal squamous cell carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1266843
|
| 40 |
Ting Yu, Li Gong, Wei Li, Qianfei Zuo, Dongping Cai, Hui Mao, Lina Wang, Jie Lin, Bin Xiao. MiR-30a suppresses metastasis of gastric adenocarcinoma via targeting FAPα. Cancer Biomarkers 2020; 27(4): 471 doi: 10.3233/CBM-190314
|
| 41 |
Zhaoye Wu, Yuqi Hua, Qiaoling Shen, Chunjing Yu. Research progress on the role of fibroblast activation protein in diagnosis and treatment of cancer. Nuclear Medicine Communications 2022; 43(7): 746 doi: 10.1097/MNM.0000000000001565
|
| 42 |
Iris J. M. Levink, Malgorzata I. Srebniak, Walter G. De Valk, Monique M. van Veghel-Plandsoen, Anja Wagner, Djuna L. Cahen, Gwenny M. Fuhler, Marco J. Bruno. An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer. International Journal of Molecular Sciences 2023; 24(6): 5097 doi: 10.3390/ijms24065097
|
| 43 |
Lei Xin, Jinfang Gao, Ziliang Zheng, Yiyou Chen, Shuxin Lv, Zhikai Zhao, Chunhai Yu, Xiaotang Yang, Ruiping Zhang. Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.648187
|
| 44 |
Paulette Mhawech-Fauceglia, Li Yan, Maryam Sharifian, Xing Ren, Song Liu, Grace Kim, Simon A. Gayther, Tanja Pejovic, Kate Lawrenson. Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer. Cancer Microenvironment 2015; 8(1): 23 doi: 10.1007/s12307-014-0153-7
|
| 45 |
Paulette Mhawech-Fauceglia, Dan Wang, Damanzoopinder Samrao, Grace Kim, Kate Lawrenson, Teodulo Meneses, Song Liu, Annie Yessaian, Tanja Pejovic. Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy. Cancer Microenvironment 2014; 7(1-2): 33 doi: 10.1007/s12307-013-0140-4
|
| 46 |
Lizzia Raffaghello, Francesco Dazzi. Classification and biology of tumour associated stromal cells. Immunology Letters 2015; 168(2): 175 doi: 10.1016/j.imlet.2015.06.016
|
| 47 |
Jie Ding, Jiangdong Qiu, Zhixin Hao, Hua Huang, Qiaofei Liu, Wenjing Liu, Chao Ren, Marcus Hacker, Taiping Zhang, Wenming Wu, Xiang Li, Li Huo. Comparing the clinical value of baseline [68 Ga]Ga-FAPI-04 PET/CT and [18F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis. European Journal of Nuclear Medicine and Molecular Imaging 2023; 50(13): 4036 doi: 10.1007/s00259-023-06297-y
|
| 48 |
Katharina Dendl, Joel Schlittenhardt, Fabian Staudinger, Clemens Kratochwil, Anette Altmann, Uwe Haberkorn, Frederik L. Giesel. The Role of Fibroblast Activation Protein Ligands in Oncologic PET Imaging. PET Clinics 2021; 16(3): 341 doi: 10.1016/j.cpet.2021.03.012
|
| 49 |
DIMITRIOS PATSOURAS, KOSTIS PAPAXOINIS, ALKIVIADIS KOSTAKIS, MICHAEL C SAFIOLEAS, ANDREAS C LAZARIS, POLYXENI NICOLOPOULOU-STAMATI. Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma. Molecular Medicine Reports 2015; 11(6): 4585 doi: 10.3892/mmr.2015.3259
|
| 50 |
Yanzhao Dong, Haiying Zhou, Ahmad Alhaskawi, Zewei Wang, Jingtian Lai, Chengjun Yao, Zhenfeng Liu, Sohaib Hasan Abdullah Ezzi, Vishnu Goutham Kota, Mohamed Hasan Abdulla Hasan Abdulla, Hui Lu. The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies. Cancers 2023; 15(4): 1193 doi: 10.3390/cancers15041193
|
| 51 |
Tomoya Kawase, Yumiko Yasui, Sohji Nishina, Yuichi Hara, Izumi Yanatori, Yasuyuki Tomiyama, Yoshihiro Nakashima, Koji Yoshida, Fumio Kishi, Masafumi Nakamura, Keisuke Hino. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0340-0
|
| 52 |
Esther M. M. Smeets, Daphne N. Dorst, Gerben M. Franssen, Merijn S. van Essen, Cathelijne Frielink, Martijn W. J. Stommel, Marija Trajkovic-Arsic, Phyllis F. Cheung, Jens T. Siveke, Ian Wilson, Alessandro Mascioni, Erik H. J. G. Aarntzen, Sanne A. M. van Lith. Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy. Cells 2023; 12(10): 1420 doi: 10.3390/cells12101420
|
| 53 |
Feng Cao, Songsong Wang, Huanqin Wang, Wei Tang. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.8155
|
| 54 |
Ziyuan Zhu, Kai Cheng, Zhang Yun, Xiang Zhang, Xiaoyu Hu, Jing Liu, Fuhao Wang, Zheng Fu, Jinbo Yue. [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging 2023; 50(11): 3425 doi: 10.1007/s00259-023-06271-8
|
| 55 |
Layla Mathieson, Richard A. O’Connor, Hazel Stewart, Paige Shaw, Kevin Dhaliwal, Gareth O. S. Williams, Alicia Megia-Fernandez, Ahsan R. Akram. Fibroblast Activation Protein Specific Optical Imaging in Non-Small Cell Lung Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.834350
|
| 56 |
Yuzhou Huang, Shurui Zhou, Yanji Luo, Jinmao Zou, Yaqing Li, Shaojie Chen, Ming Gao, Kaihong Huang, Guoda Lian. Development and validation of a radiomics model of magnetic resonance for predicting liver metastasis in resectable pancreatic ductal adenocarcinoma patients. Radiation Oncology 2023; 18(1) doi: 10.1186/s13014-023-02273-w
|
| 57 |
Luan-Jing Zhang, Ke-Bing Wang, Long-shan Liu, Lian-zhou Chen, Bao-Gang Peng, Li-Jian Liang, Zhi Li, Ling Xue, Wen Li, Jing-Tang Xia. Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-571
|
| 58 |
Woosol Chris Hong, Da Eun Lee, Hyeon Woong Kang, Myeong Jin Kim, Minsoo Kim, Ju Hyun Kim, Sungsoon Fang, Hyo Jung Kim, Joon Seong Park. CD74 Promotes a Pro-Inflammatory Tumor Microenvironment by Inducing S100A8 and S100A9 Secretion in Pancreatic Cancer. International Journal of Molecular Sciences 2023; 24(16): 12993 doi: 10.3390/ijms241612993
|
| 59 |
Sunitha Kakarla, Xiao-Tong Song, Stephen Gottschalk. Cancer-associated fibroblasts as targets for immunotherapy. Immunotherapy 2012; 4(11): 1129 doi: 10.2217/imt.12.112
|
| 60 |
Yentl Van Rymenant, Muhammet Tanc, Roos Van Elzen, An Bracke, Olivier De Wever, Koen Augustyns, Anne-Marie Lambeir, Mark Kockx, Ingrid De Meester, Pieter Van Der Veken. In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes. Frontiers in Chemistry 2021; 9 doi: 10.3389/fchem.2021.640566
|
| 61 |
K. Sideras, H. Braat, J. Kwekkeboom, C.H. van Eijck, M.P. Peppelenbosch, S. Sleijfer, M. Bruno. Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. Cancer Treatment Reviews 2014; 40(4): 513 doi: 10.1016/j.ctrv.2013.11.005
|
| 62 |
Roger Yazbeck, Simone E. Jaenisch, Catherine A. Abbott. Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein. Protoplasma 2018; 255(1): 375 doi: 10.1007/s00709-017-1129-5
|
| 63 |
Pawel Rasinski, Siri af Burén, Maria Holstensson, Ted Nilsson, Louiza Loizou, Thuy A. Tran, Ernesto Sparrelid, J. Matthias Löhr, Rimma Axelsson. Tumor Characterization by [68Ga]FAPI-46 PET/CT Can Improve Treatment Selection for Pancreatic Cancer Patients: An Interim Analysis of a Prospective Clinical Trial. Journal of Nuclear Medicine 2023; 64(8): 1232 doi: 10.2967/jnumed.123.265481
|
| 64 |
Stephanie Bonan, Jean Albrengues, Eloise Grasset, Sanya-Eduarda Kuzet, Nicolas Nottet, Isabelle Bourget, Thomas Bertero, Bernard Mari, Guerrino Meneguzzi, Cedric Gaggioli. Membrane-bound ICAM-1 contributes to the onset of proinvasive tumor stroma by controlling acto-myosin contractility in carcinoma-associated fibroblasts. Oncotarget 2017; 8(1): 1304 doi: 10.18632/oncotarget.13610
|
| 65 |
Patrick Conen, Kai J. Dautzenberg, Felix M. Mottaghy. Nuclear Medicine and Molecular Imaging. 2022; : 353 doi: 10.1016/B978-0-12-822960-6.00039-9
|
| 66 |
John Gehris, Charlie Ervin, Charlotte Hawkins, Sydney Womack, Amelia M. Churillo, Jonathan Doyle, Albert J. Sinusas, Francis G. Spinale. Fibroblast activation protein: Pivoting cancer/chemotherapeutic insight towards heart failure. Biochemical Pharmacology 2024; 219: 115914 doi: 10.1016/j.bcp.2023.115914
|
| 67 |
Přemysl Frič, Aleksi Šedo, Jan Škrha, Petr Bušek, Martin Laclav, Pavel Škrha, Miroslav Zavoral. Early detection of sporadic pancreatic cancer: time for change. European Journal of Gastroenterology & Hepatology 2017; 29(8): 885 doi: 10.1097/MEG.0000000000000904
|
| 68 |
Fang Liu, Li Qi, Bao Liu, Jie Liu, Hua Zhang, DeHai Che, JingYan Cao, Jing Shen, JianXiong Geng, Yi Bi, LieGuang Ye, Bo Pan, Yan Yu, John Green. Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis. PLOS ONE 2015; 10(3): e0116683 doi: 10.1371/journal.pone.0116683
|
| 69 |
F. A. Vuijk, L. D. A. N. de Muynck, L. C. Franken, O. R. Busch, J. W. Wilmink, M. G. Besselink, B. A. Bonsing, S. S. Bhairosingh, P. J. K. Kuppen, J. S. D. Mieog, C. F. M. Sier, A. L. Vahrmeijer, J. Verheij, A. Fariňa-Sarasqueta, R. J. Swijnenburg. Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73242-6
|
| 70 |
Travis W. Bainbridge, Diana Ronai Dunshee, Noelyn M. Kljavin, Nicholas J. Skelton, Junichiro Sonoda, James A. Ernst. Selective Homogeneous Assay for Circulating Endopeptidase Fibroblast Activation Protein (FAP). Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-12900-8
|
| 71 |
Raisa A. Glabman, Colleen P. Olkowski, Hannah A. Minor, Laura L. Bassel, Noemi Kedei, Peter L. Choyke, Noriko Sato. Tumor Suppression by Anti-Fibroblast Activation Protein Near-Infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts. Cancers 2024; 16(2): 449 doi: 10.3390/cancers16020449
|
| 72 |
Fiona M. Keane, Tsun-Wen Yao, Stefanie Seelk, Margaret G. Gall, Sumaiya Chowdhury, Sarah E. Poplawski, Jack H. Lai, Youhua Li, Wengen Wu, Penny Farrell, Ana Julia Vieira de Ribeiro, Brenna Osborne, Denise M.T. Yu, Devanshi Seth, Khairunnessa Rahman, Paul Haber, A. Kemal Topaloglu, Chuanmin Wang, Sally Thomson, Annemarie Hennessy, John Prins, Stephen M. Twigg, Susan V. McLennan, Geoffrey W. McCaughan, William W. Bachovchin, Mark D. Gorrell. Quantitation of fibroblast activation protein (FAP)‐specific protease activity in mouse, baboon and human fluids and organs. FEBS Open Bio 2014; 4(1): 43 doi: 10.1016/j.fob.2013.12.001
|
| 73 |
Chun Mei Hou, Xue Mei Qu, Jian Zhang, Ting Ting Ding, Wei Han, Guang Chuan Ji, Zhao Hua Zhong, He Chen, FengMin Zhang. Fibroblast activation proteins-α suppress tumor immunity by regulating T cells and tumor-associated macrophages. Experimental and Molecular Pathology 2018; 104(1): 29 doi: 10.1016/j.yexmp.2017.12.003
|
| 74 |
Masahiro Tanemura, Eiji Miyoshi, Hiroaki Nagano, Hidetoshi Eguchi, Katsuyoshi Matsunami, Kiyomi Taniyama, Nobutaka Hatanaka, Hiroki Akamatsu, Masaki Mori, Yuichiro Doki. Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction. World Journal of Gastroenterology 2015; 21(40): 11396-11410 doi: 10.3748/wjg.v21.i40.11396
|
| 75 |
FUMING ZI, JINGSONG HE, DONGHUA HE, YI LI, LI YANG, ZHEN CAI. Fibroblast activation protein α in tumor microenvironment: Recent progression and implications (Review). Molecular Medicine Reports 2015; 11(5): 3203 doi: 10.3892/mmr.2015.3197
|
| 76 |
Petr Busek, Zdislava Vanickova, Petr Hrabal, Marek Brabec, Premysl Fric, Miroslav Zavoral, Jan Skrha, Klara Kmochova, Martin Laclav, Bohus Bunganic, Koen Augustyns, Pieter Van Der Veken, Aleksi Sedo. Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma. Pancreatology 2016; 16(5): 829 doi: 10.1016/j.pan.2016.06.001
|
| 77 |
Mária Bodnár Mikulová, Peter Mikuš. Advances in Development of Radiometal Labeled Amino Acid-Based Compounds for Cancer Imaging and Diagnostics. Pharmaceuticals 2021; 14(2): 167 doi: 10.3390/ph14020167
|
| 78 |
Michal Zubaľ, Barbora Výmolová, Ivana Matrasová, Petr Výmola, Jana Vepřková, Martin Syrůček, Robert Tomáš, Zdislava Vaníčková, Evžen Křepela, Dora Konečná, Petr Bušek, Aleksi Šedo. Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours. Pathology 2023; 55(6): 806 doi: 10.1016/j.pathol.2023.05.003
|
| 79 |
Ana Carolinne Da Silva, Millena Prata Jammal, Paula Carolina Arvelos Crispim, Eddie Fernando Candido Murta, Rosekeila Simões Nomelini. The Role of Stroma in Ovarian Cancer. Immunological Investigations 2020; 49(4): 406 doi: 10.1080/08820139.2019.1658770
|
| 80 |
S. K. Daniel, K. M. Sullivan, K. P. Labadie, V. G. Pillarisetty. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma. Clinical and Translational Medicine 2019; 8(1) doi: 10.1186/s40169-019-0226-9
|
| 81 |
Manish Ora, Neetu Soni, Aftab Hasan Nazar, Manish Dixit, Rohit Singh, Savita Puri, Michael M. Graham, Sanjay Gambhir. Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions. Journal of Nuclear Medicine 2023; 64(7): 1001 doi: 10.2967/jnumed.123.265594
|
| 82 |
Yinghao Meng, Jieyu Yu, Mengmeng Zhu, Jian Zhou, Na Li, Fang Liu, Hao Zhang, Xu Fang, Jing Li, Xiaocheng Feng, Li Wang, Hui Jiang, Jianping Lu, Chengwei Shao, Yun Bian. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma. Abdominal Radiology 2022; 47(8): 2822 doi: 10.1007/s00261-022-03512-6
|
| 83 |
Allison A. Fitzgerald, Louis M. Weiner. The role of fibroblast activation protein in health and malignancy. Cancer and Metastasis Reviews 2020; 39(3): 783 doi: 10.1007/s10555-020-09909-3
|
| 84 |
Jingbo Li, Rui Kang, Daolin Tang. Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma. Cancer Communications 2021; 41(8): 642 doi: 10.1002/cac2.12188
|
| 85 |
Behzad Baradaran, Roya Shahbazi, Monireh Khordadmehr. Dysregulation of key microRNAs in pancreatic cancer development. Biomedicine & Pharmacotherapy 2019; 109: 1008 doi: 10.1016/j.biopha.2018.10.177
|
| 86 |
Sung Yeon Park, Hye Min Kim, Ja Seung Koo. Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer. Breast Cancer Research and Treatment 2015; 149(3): 727 doi: 10.1007/s10549-015-3291-9
|
| 87 |
Naoki Yanagawa, Mayu Sugai, Shunsuke Shikanai, Ryo Sugimoto, Mitsumasa Osakabe, Noriyuki Uesugi, Hajime Saito, Makoto Maemondo, Tamotsu Sugai. High expression of fibroblast‐activating protein is a prognostic marker in non‐small cell lung carcinoma. Thoracic Cancer 2022; 13(16): 2377 doi: 10.1111/1759-7714.14579
|
| 88 |
Hao Wang, Ruixue Huo, Kexin He, Li Cheng, Shan Zhang, Minhao Yu, Wei Zhao, Hui Li, Junli Xue. Perineural invasion in colorectal cancer: mechanisms of action and clinical relevance. Cellular Oncology 2024; 47(1): 1 doi: 10.1007/s13402-023-00857-y
|
| 89 |
Wanling Ma, Na Li, Weiwei Zhao, Jing Ren, Mengqi Wei, Yong Yang, Yingmei Wang, Xin Fu, Zhuoli Zhang, Andrew C. Larson, Yi Huan. Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Pancreatic Cancer. Journal of Computer Assisted Tomography 2016; 40(5): 709 doi: 10.1097/RCT.0000000000000434
|
| 90 |
Petra Dvořáková, Petr Bušek, Tomáš Knedlík, Jiří Schimer, Tomáš Etrych, Libor Kostka, Lucie Stollinová Šromová, Vladimír Šubr, Pavel Šácha, Aleksi Šedo, Jan Konvalinka. Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein. Journal of Medicinal Chemistry 2017; 60(20): 8385 doi: 10.1021/acs.jmedchem.7b00767
|
| 91 |
Ruohua Chen, Xinlan Yang, Xiaofeng Yu, Xiang Zhou, Yee Ling Ng, Haitao Zhao, Lianghua Li, Gang Huang, Yun Zhou, Jianjun Liu. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [68Ga]Ga-FAPI-04. European Journal of Nuclear Medicine and Molecular Imaging 2023; 50(3): 929 doi: 10.1007/s00259-022-06010-5
|
| 92 |
Liang Zhao, Yizhen Pang, Long Sun, Qin Lin, Hua Wu, Haojun Chen. Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer. PET Clinics 2023; 18(3): 295 doi: 10.1016/j.cpet.2023.02.001
|
| 93 |
Lukáš Urban, Matúš Čoma, Lukáš Lacina, Pavol Szabo, Jana Sabová, Tomáš Urban, Hubert Šuca, Štefan Lukačín, Robert Zajíček, Karel Smetana, Peter Gál. Heterogeneous response to TGF-β1/3 isoforms in fibroblasts of different origins: implications for wound healing and tumorigenesis. Histochemistry and Cell Biology 2023; 160(6): 541 doi: 10.1007/s00418-023-02221-5
|
| 94 |
Peifang Song, Quisha Pan, Zhaohui Sun, Liwei Zou, Ling Yang. Fibroblast activation protein alpha: Comprehensive detection methods for drug target and tumor marker. Chemico-Biological Interactions 2022; 354: 109830 doi: 10.1016/j.cbi.2022.109830
|
| 95 |
Zuzana Kahounová, Daniela Kurfürstová, Jan Bouchal, Gvantsa Kharaishvili, Jiří Navrátil, Ján Remšík, Šárka Šimečková, Vladimír Študent, Alois Kozubík, Karel Souček. The fibroblast surface markers FAP, anti‐fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial‐to‐mesenchymal transition. Cytometry Part A 2018; 93(9): 941 doi: 10.1002/cyto.a.23101
|
| 96 |
María Laura Gutiérrez, Luis Muñoz-Bellvís, Alberto Orfao. Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact. Cancers 2021; 13(17): 4451 doi: 10.3390/cancers13174451
|
| 97 |
Cole R Drifka, Jo Tod, Agnes G Loeffler, Yuming Liu, Gareth J Thomas, Kevin W Eliceiri, W John Kao. Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis. Modern Pathology 2015; 28(11): 1470 doi: 10.1038/modpathol.2015.97
|
| 98 |
Caitlyn Smith, Wei Zheng, Jixin Dong, Yaohong Wang, Jinping Lai, Xiuli Liu, Feng Yin. Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy. World Journal of Gastroenterology 2022; 28(27): 3297-3313 doi: 10.3748/wjg.v28.i27.3297
|
| 99 |
Johannes Byrling, Agata Sasor, Johan Nilsson, Katarzyna Said Hilmersson, Roland Andersson, Bodil Andersson. Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma. Scandinavian Journal of Gastroenterology 2020; 55(1): 82 doi: 10.1080/00365521.2019.1708449
|
| 100 |
Mi-Gyeong Kim, Yuna Shon, Jinyoung Kim, Yu-Kyoung Oh. Selective Activation of Anticancer Chemotherapy by Cancer-Associated Fibroblasts in the Tumor Microenvironment. Journal of the National Cancer Institute 2017; 109(1): djw186 doi: 10.1093/jnci/djw186
|
| 101 |
Julio César Villegas-Pineda, Adrián Ramírez-de-Arellano, Lesly Jazmín Bueno-Urquiza, Mélida del Rosario Lizarazo-Taborda, Ana Laura Pereira-Suárez. Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1106757
|
| 102 |
Guan-Min Jiang, Wei Xu, Jun Du, Kun-Shui Zhang, Qiu-Gui Zhang, Xiao-Wei Wang, Zhi-Gang Liu, Shuang-Quan Liu, Wan-Ying Xie, Hui-Fang Liu, Jing-Shi Liu, Bai-Ping Wu. The application of the fibroblast activation protein α-targeted immunotherapy strategy. Oncotarget 2016; 7(22): 33472 doi: 10.18632/oncotarget.8098
|
| 103 |
Karl Knipper, Alexander I. Damanakis, Yue Zhao, Christiane J. Bruns, Thomas Schmidt, Felix C. Popp, Alexander Quaas, Su Ir Lyu. Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(7): 2049 doi: 10.3390/cancers15072049
|
| 104 |
Volker Teichgräber, Carmen Monasterio, Krishna Chaitanya, Regina Boger, Katrin Gordon, Thomas Dieterle, Dirk Jäger, Stefan Bauer. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro. Advances in Medical Sciences 2015; 60(2): 264 doi: 10.1016/j.advms.2015.04.006
|
| 105 |
Sang Yun Ha, So-Young Yeo, Yan-hiua Xuan, Seok-Hyung Kim, Jörg D. Hoheisel. The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma. PLoS ONE 2014; 9(6): e99955 doi: 10.1371/journal.pone.0099955
|
| 106 |
Jialing Cai, Depeng Yang, Handi Sun, Lixing Xiao, Fang Han, Mengmeng Zhang, Lu Zhou, Meiyi Jiang, Qinghua Jiang, Yu Li, Huan Nie. A multifactorial analysis of FAP to regulate gastrointestinal cancers progression. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1183440
|
| 107 |
Kunal Ramesh Chandekar, Arun Prashanth, Sobhan Vinjamuri, Rakesh Kumar. FAPI PET/CT Imaging—An Updated Review. Diagnostics 2023; 13(12): 2018 doi: 10.3390/diagnostics13122018
|
| 108 |
Artur Mezheyeuski, Ulrika Segersten, Lina Wik Leiss, Per-Uno Malmström, Jiri Hatina, Arne Östman, Carina Strell. Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-019-55013-0
|
| 109 |
Mohammed H. Abuwarwar, Alfie T. Baker, Jeffrey Harding, Natalie L. Payne, Andras Nagy, Konstantin Knoblich, Anne L. Fletcher. In Vitro Suppression of T Cell Proliferation Is a Conserved Function of Primary and Immortalized Human Cancer-Associated Fibroblasts. International Journal of Molecular Sciences 2021; 22(4): 1827 doi: 10.3390/ijms22041827
|
| 110 |
Hiroyoshi Y. Tanaka, Takuya Nakazawa, Atsushi Enomoto, Atsushi Masamune, Mitsunobu R. Kano. Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment. Cancers 2023; 15(3): 724 doi: 10.3390/cancers15030724
|
| 111 |
Gi Jeong Kim, Hyungjin Rhee, Jeong Eun Yoo, Jung Eun Ko, Jee San Lee, Hyunki Kim, Jin Sub Choi, Young Nyun Park, Philip C. Trackman. Increased Expression of CCN2, Epithelial Membrane Antigen, and Fibroblast Activation Protein in Hepatocellular Carcinoma with Fibrous Stroma Showing Aggressive Behavior. PLoS ONE 2014; 9(8): e105094 doi: 10.1371/journal.pone.0105094
|
| 112 |
Hajime Kashima, Kazuhiro Noma, Toshiaki Ohara, Takuya Kato, Yuki Katsura, Satoshi Komoto, Hiroaki Sato, Ryoichi Katsube, Takayuki Ninomiya, Hiroshi Tazawa, Yasuhiro Shirakawa, Toshiyoshi Fujiwara. Cancer‐associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma. International Journal of Cancer 2019; 144(4): 828 doi: 10.1002/ijc.31953
|
| 113 |
Sunitha Kakarla, Kevin KH Chow, Melinda Mata, Donald R Shaffer, Xiao-Tong Song, Meng-Fen Wu, Hao Liu, Lisa L Wang, David R Rowley, Klaus Pfizenmaier, Stephen Gottschalk. Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma. Molecular Therapy 2013; 21(8): 1611 doi: 10.1038/mt.2013.110
|
| 114 |
Jean Albrengues, Thomas Bertero, Eloise Grasset, Stephanie Bonan, Majdi Maiel, Isabelle Bourget, Claude Philippe, Cecilia Herraiz Serrano, Samia Benamar, Olivier Croce, Victoria Sanz-Moreno, Guerrino Meneguzzi, Chloe C. Feral, Gael Cristofari, Cedric Gaggioli. Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts. Nature Communications 2015; 6(1) doi: 10.1038/ncomms10204
|
| 115 |
Robert J. Torphy, Yuwen Zhu, Richard D. Schulick. Immunotherapy for pancreatic cancer: Barriers and breakthroughs. Annals of Gastroenterological Surgery 2018; 2(4): 274 doi: 10.1002/ags3.12176
|
| 116 |
Suk Woo Lee, Mijeong Jeon, Hyo-Seol Lee, Je Seon Song, Heung-Kyu Son, Hyung-Jun Choi, Han-Sung Jung, Seok-Jun Moon, Wonse Park, Seong-Oh Kim. Comparative Gene-Expression Analysis of Periodontal Ligament and Dental Pulp in the Human Permanent Teeth. THE JOURNAL OF THE KOREAN ACADEMY OF PEDTATRIC DENTISTRY 2016; 43(2): 166 doi: 10.5933/JKAPD.2016.43.2.166
|